HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Munehide Matsuhisa Selected Research

Insulin Infusion Systems

3/2017Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury.
1/2014Usefulness of artificial endocrine pancreas during resection of insulinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Munehide Matsuhisa Research Topics

Disease

37Type 2 Diabetes Mellitus (MODY)
02/2021 - 07/2002
27Insulin Resistance
12/2019 - 02/2003
23Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2022 - 08/2002
12Atherosclerosis
09/2022 - 03/2005
11Carotid Artery Diseases
04/2016 - 08/2002
10Hyperglycemia
07/2019 - 02/2003
9Hypoglycemia (Reactive Hypoglycemia)
10/2021 - 01/2014
7Diabetes Mellitus
09/2022 - 09/2011
6Diabetic Angiopathies (Diabetic Angiopathy)
09/2019 - 10/2005
5Diabetic Nephropathies (Diabetic Nephropathy)
09/2022 - 11/2010
4Body Weight (Weight, Body)
09/2021 - 11/2007
4Glucose Intolerance
12/2019 - 01/2002
3Diabetes Complications
09/2022 - 09/2008
3Cardiovascular Diseases (Cardiovascular Disease)
06/2016 - 02/2011
3Hypertension (High Blood Pressure)
01/2016 - 08/2008
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2013 - 07/2008
3Obesity
07/2007 - 06/2004
2Albuminuria
12/2021 - 02/2011
2Sarcopenia
09/2021 - 09/2019
2Inflammation (Inflammations)
01/2020 - 07/2019
2Chronic Renal Insufficiency
01/2020 - 01/2020
2Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 12/2019
2Infections
01/2020 - 08/2008
2Muscle Weakness
07/2019 - 05/2017
2Neoplasms (Cancer)
09/2017 - 01/2014
2Dyslipidemias (Dyslipidemia)
01/2016 - 01/2014
2Hyperinsulinism (Hyperinsulinemia)
09/2005 - 06/2004
1Drug-Related Side Effects and Adverse Reactions
10/2020
1Nausea
01/2020
1Vomiting
01/2020
1Pain (Aches)
01/2020
1Pituitary Neoplasms (Pituitary Adenoma)
09/2017
1Acromegaly
09/2017
1Acute Kidney Injury (Acute Renal Failure)
03/2017
1Arteriosclerosis
01/2016

Drug/Important Bio-Agent (IBA)

31Insulin (Novolin)FDA Link
09/2022 - 02/2003
30Glucose (Dextrose)FDA LinkGeneric
07/2021 - 01/2002
11Biomarkers (Surrogate Marker)IBA
12/2021 - 08/2008
10Blood Glucose (Blood Sugar)IBA
07/2021 - 10/2004
7Advanced Glycation End ProductsIBA
09/2019 - 11/2005
6AlbuminsIBA
12/2021 - 07/2008
6Insulin Glargine (Lantus)FDA Link
02/2021 - 12/2016
5AdiponectinIBA
01/2021 - 07/2007
4Pioglitazone (Actos)FDA Link
01/2014 - 04/2007
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2022 - 07/2008
3DNA (Deoxyribonucleic Acid)IBA
07/2022 - 01/2002
3Glucagon (Glukagon)FDA Link
01/2020 - 11/2007
3Hypoglycemic Agents (Hypoglycemics)IBA
05/2018 - 01/2018
3Indicators and Reagents (Reagents)IBA
02/2013 - 02/2008
3human esRAGE proteinIBA
05/2009 - 11/2005
3Proteins (Proteins, Gene)FDA Link
07/2007 - 01/2005
3JNK Mitogen-Activated Protein KinasesIBA
01/2006 - 10/2004
2Pharmaceutical PreparationsIBA
01/2020 - 04/2010
2Testosterone (Sustanon)FDA Link
01/2019 - 04/2007
2Hemoglobins (Hemoglobin)IBA
01/2018 - 10/2005
2Sodium-Glucose Transporter 2 InhibitorsIBA
01/2018 - 01/2016
2Sitagliptin Phosphate (Januvia)FDA Link
11/2017 - 06/2016
2CopperIBA
01/2013 - 01/2009
2CalciumIBA
01/2013 - 01/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2010 - 01/2009
2Sucrose (Saccharose)IBA
01/2009 - 02/2008
2Oxygen (Dioxygen)IBA
03/2005 - 01/2005
2Molecular Chaperones (Chaperone, Molecular)IBA
03/2005 - 01/2005
2AntioxidantsIBA
02/2005 - 07/2002
1Heparin Cofactor IIIBA
12/2021
1CreatinineIBA
12/2021
1ThrombinFDA Link
12/2021
1Fatty Acid-Binding ProteinsIBA
12/2021
1Insulin-Like Growth Factor I (IGF-1)IBA
09/2021
1Phosphates (Orthophosphate)IBA
09/2021
1InsulinsIBA
10/2020
1MineralsIBA
01/2020
1Hormones (Hormone)IBA
01/2019
1OsteocalcinIBA
01/2019
1LiraglutideFDA Link
10/2018
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2018
1Dipeptidyl-Peptidase IV InhibitorsIBA
10/2018
1SymportersIBA
01/2018
1SodiumIBA
01/2018
1Growth Hormone (Somatotropin)IBA
09/2017
1Octreotide (Sandostatin)FDA LinkGeneric
09/2017
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
09/2017
1insulin degludecIBA
03/2017
1IncretinsIBA
06/2016
1Collagen Type I (Type I Collagen)IBA
04/2016
1Matrix Metalloproteinases (MMPs)IBA
04/2016
1EnzymesIBA
03/2016
1Chlormadinone Acetate (Chlormadinone)IBA
01/2016

Therapy/Procedure

12Therapeutics
10/2018 - 06/2005
10Glycemic Control
10/2021 - 07/2008
4Injections
09/2022 - 10/2005
3Communication Aids for Disabled (TDD)
02/2022 - 11/2012
2Transplantation
12/2019 - 08/2008
2Drug Therapy (Chemotherapy)
05/2018 - 03/2018
2Insulin Infusion Systems
03/2017 - 01/2014
2Kidney Transplantation
11/2010 - 08/2008
1Renal Dialysis (Hemodialysis)
01/2020
1Pancreas Transplantation
12/2019
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2019
1Hepatectomy
03/2017